Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Cannae Cnne Stock Worth Holding Price At 12.38 Up 1.35 20260408 Will Ezcorp Ezpw Stock Rise In 2026 Price At 26.37 Down 3.02 20260406 What Is The Price Target For Dxl Dxlg Stock Price At 0.53 Up 2.65 20260408 Is Sab Biotherapeutics Sabs Stock Testing Support Price At 3.89 Up 0.26 20260406 What Are Hedge Funds Doing With Xponential Fitness Xpof Stock Xpof Q4 Earnings Misses Estimates By 0.89 20260408 1 How Rumble RUM differentiates itself from competitors Investors Pile In 20260508 SGRY Surgery Partners Inc reports 62 percent Q4 2025 revenue growth shares edge higher despite steep earnings miss Celldex CLDX Stock Performance Drivers Modest Uptick 20260418 AISP Airship AI Holdings Inc reports far worse than expected Q3 2025 per share loss pushing its shares down 237 today Why Bilibili BILI ability to generate cash matters Selling Pressure 20260507 SRAD Sportradar Group AG rises nearly 4 percent despite wide Q4 2025 EPS miss relative to consensus analyst forecasts Seer SEER Stock Portfolio Review Marginal Loss 20260420 RXT Rackspace Technology Q1 2026 earnings disappoint with 695 EPS miss shares slide 524 Mesa Laboratories MLAB Stock Trend Analysis Touches High 20260422 What is the outlook for Pop Culture CPOP stock Pursuit PRSU Stock Climbs Selling Pressure 20260420 What TechPrecision TPCS is doing that smart money tracks Strengthens 20260511 Ecolab Inc ECL PreEarnings Analysis Favorable Signals Point to Q1 2026 EPS Beat Cisco Systems Inc CSCO Navigating Geopolitical Headwinds and AIDriven Market Dynamics Ahead of Quarterly Release The labor dynamics in Great Elm GECCG results GECCG Q4 Earnings Great Elm Investment Income Remains Consistent How sustainable is Sutro Biopharma STRO profit margins Runs Up 20260508 VHI Valhi notches 161 percent stock gain despite steep Q4 2025 earnings per share miss against analyst estimates Gilead Sciences GILD Valuation Discrepancy Emerges Between LongTerm Shareholder Returns and NearTerm Trading Dynamics How much upside is really left in Bon Natural BON Grinds Higher 20260503 Cingulate CING Investment Thesis Q4 2025 Profit Disappoints Chevron Corporation CVX CEO Flags Inadequate Venezuelan Policy Reforms for NearTerm Production Upside Compass Div CODI Slips 059 Testing 1128 Support 20260520 Fortress Biotech FBIO Q4 2025 Miss What Went Wrong